Reference : A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
Scientific journals : Letter to the editor
Human health sciences : Cardiovascular & respiratory systems
http://hdl.handle.net/2268/211751
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
English
LANCELLOTTI, Patrizio [Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie >]
Oury, Cécile mailto [Université de Liège > Département des sciences biomédicales et précliniques > GIGA-R : GIGA - Cardiovascular Sciences >]
May-2017
New England Journal of Medicine
Massachusetts Medical Society
376
e38
Yes (verified by ORBi)
International
0028-4793
1533-4406
Waltham
MA
[en] RNAi ; hypercholesterolemia ; clinical trial
http://hdl.handle.net/2268/211751
10.1056/NEJMc1703361

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
nejmc1703361_letter Lancellotti_Oury.pdfPublisher postprint72.09 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.